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Eosinophilic esophagitis (EoE) is an immune mediated disease characterized clinically by 
symptoms of esophageal dysfunction and histologically by a marked eosinophilic infiltrate 
of the esophageal epithelium in the absence of other causes of esophageal eosinophilia. EoE 
became increasingly recognized in the pediatric population in the mid-1990s, and thereafter 
in the adult patients. Over time, there has been an increase in awareness and possibly 
prevalence and incidence of EoE.[1, 2] Currently, the most reliable and objective method to 
diagnose EoE and/or assess disease status is via performing esophagogastroduodenoscopy 
(EGD) with biopsies, and patients could undergo multiple EGDs in a relatively short span of 
disease duration. Normal endoscopic appearance of mucosa does not rule out EoE.
Not only are repeated EGDs invasive, but also require some level of sedation which in the 
pediatric population often translates into general anesthesia. This leads to involvement of an 
anesthesiologist, and use of costly facilities such as operating room, resulting in significant 
health-care costs. Children may experience negative health-related quality of life (HRQoL) 
due to persistent symptoms and repeated procedures.[3] As such, it is imperative to look for 
alternate and newer methods which would be accurate, safe, comprehensive and less 
expensive for monitoring EoE.
Several, potentially less-invasive, techniques are being studied for monitoring EoE disease 
activity. Fractionated exhaled nitric oxide (FeNO) has been used to assess eosinophil-
predominant asthma and EoE. Leung et al[4] measured FeNO in nonasthmatic subjects with 
active esophagitis before and after treatment with topical steroids. FeNO levels declined post 
treatment. Subbarao et al [5] prospectively measured serum IL-5, serum eosinophil-derived 
neurotoxin (EDN), and stool EDN in children with EoE and controls at multiple time-points. 
Serum EDN levels were significantly higher in subjects with active EoE than in controls or 
those in remission. Esophageal string test involves collection of esophageal luminal 
secretions by a string that unravels after a weighted gelatin capsule is swallowed. 
Preliminary data suggests correlation between disease activity and levels of eosinophil 
derived granule proteins captured on the string. Another ingestible gelatin capsule, 
Cytosponge, contains a compressed mesh attached to a string that collects esophageal 
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mucosal secretions. Katzka et al [6] showed in a pilot study that the sponge is safe and 
accurate, compared to endoscopic biopsy, in assessing esophageal eosinophilia. Patients with 
active EoE were identified with 83% sensitivity, and (Cytosponge) was preferred over 
sedated EGD by all patients studied. The study is promising and if validated on a large 
patient population, might very well become the new method to monitor EoE in adult 
population. The third capsule based test uses a high-speed fiber based reflectance confocal 
microscopy technique termed Spectrally Encoded Confocal Microscopy (SECM). Its images 
correlate well, with high sensitivity and specificity, with results obtained by conventional 
histology.[7] The EndoFLIP system uses impedance planimetry to measure esophageal 
distension which is reduced in patients with EoE compared to the controls.[8] This test 
however, may ignore regional variation along the esophagus and is somewhat invasive. 
Microarray technology has been harnessed as in a molecular EoE Diagnostic Panel built on 
Taqman-qPCR based low density array system. Its limitations would be turnaround time, 
technical complexity of the messenger RNA microarray, and potential costs.[9] Many of 
these technologies are not commercially available; hence it is difficult to predict the 
economic burden these will have on the patient and the health care system.
In the current issue of the Journal, the Colorado group reports on a prospective study, 
wherein unsedated transnasal endoscopies (TNE) with biopsies were performed to monitor 
EoE in 21 children.[10] Authors provide a single institution experience with data on 
important determinants such as cost, safety and efficacy. Three proximal and three distal 
esophageal mucosal biopsies were obtained with biopsy surface area comparable to biopsies 
with standard EGD. No serious adverse events related to the procedure were reported. The 
authors report high procedure acceptance rates where all parents and 76.2% of subjects 
would undergo the TNE again over traditional EGD. The charges associated with TNE at 
study site were 60.1% less than prior EGD with biopsies. This study is promising and opens 
doors to newer, less invasive methods to monitor EoE. It provides encouraging preliminary 
data, and should prompt further study with aim of validating the preliminary results. While 
TNE is not a non-invasive test, and some limitations include limited endoscopic and 
histological evaluation of gastric and duodenal mucosa, and additional training, albeit of a 
short duration, is required of gastroenterologists desiring to perform TNE. Some other 
unanswered questions are about the size of biopsy samples. While authors report that that 
their sample size was similar to that obtained during standard EGD, this needs further 
validation especially as EoE can be a patchy disease. The other concern which can be better 
addressed in a multicenter study is of the patient acceptance rate. There is a potential for 
patient selection bias in a single center study such as seen in a large adult study where TNE 
was declined by half of the patients.[11] In our clinical and research experience the 
procedure is well tolerated by most but not all patients; 80% of patients undergoing TNE are 
willing to undergo the procedure again.
In conclusion, unsedated TNE has opened the vistas of new directions and is among the 
expanding list of novel techniques for monitoring EoE in both pediatric and adult patients. It 
is cardinally important that we continue to search for less invasive techniques. With 
increasing body of knowledge on EoE and widening pool of researchers, we are hopeful that 
monitoring of EoE will continue to evolve and grow. We have to tread yet a few more miles, 
but the sanguine hope is that we will definitely get there... sooner than tomorrow.
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HRQoL Health-related quality of life
FeNO Fractionated exhaled nitric oxide
EDN Serum eosinophil-derived neurotoxin
SECM Spectrally Encoded Confocal Microscopy
TNE Transnasal endoscopy
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